abstract |
A first vaccine component containing one or more antigens from Mycobacterium tuberculosis, Mycobacterium vaccae or M. bovis, and an interferon gene stimulator A Mycobacterium tuberculosis vaccine formulated for intranasal administration, comprising a second vaccine component comprising a (STING) activator. |